157 related articles for article (PubMed ID: 36272131)
1. Protocol to quantify and phenotype SARS-CoV-2-specific T cell response using a rapid flow-cytometry-based whole blood assay.
Mutavhatsindi H; Riou C
STAR Protoc; 2022 Dec; 3(4):101771. PubMed ID: 36272131
[TBL] [Abstract][Full Text] [Related]
2. FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses.
Tiezzi C; Rossi M; Vecchi A; Doselli S; Penna A; Fisicaro P; Montali I; Ceccatelli Berti C; Reverberi V; Montali A; Missale G; Ferrari C; Boni C
STAR Protoc; 2023 Dec; 4(4):102584. PubMed ID: 37733600
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens.
Weskamm LM; Dahlke C; Addo MM
STAR Protoc; 2022 Dec; 3(4):101902. PubMed ID: 36595922
[TBL] [Abstract][Full Text] [Related]
4. A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19.
Martin S; Jégou G; Nicolas A; Le Gallo M; Chevet É; Godey F; Avril T
STAR Protoc; 2022 Mar; 3(1):101229. PubMed ID: 35287269
[TBL] [Abstract][Full Text] [Related]
5. A combined fine needle aspiration and spectral flow cytometry approach to assess human germinal center responses to SARS-CoV-2 vaccination.
Bettini E; Lederer K; Sharpe H; Kaminski M; Jones L; Locci M
STAR Protoc; 2022 Dec; 3(4):101840. PubMed ID: 36595931
[TBL] [Abstract][Full Text] [Related]
6. Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques.
Cottignies-Calamarte A; He F; Zhu A; Real F; Bomsel M
STAR Protoc; 2023 Dec; 4(4):102593. PubMed ID: 37738115
[TBL] [Abstract][Full Text] [Related]
7. A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients.
Goh YS; Ng LFP; Renia L
STAR Protoc; 2021 Sep; 2(3):100671. PubMed ID: 34179835
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 CD8
Mateyka LM; Grass V; Pichlmair A; Busch DH; D'Ippolito E
STAR Protoc; 2022 Dec; 3(4):101699. PubMed ID: 36152303
[TBL] [Abstract][Full Text] [Related]
9. Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19.
Villemonteix J; Cohen L; Guihot A; Guérin V; Moulin C; Caseris M; Carol A; Bonacorsi S; Carcelain G
Immun Inflamm Dis; 2022 Oct; 10(10):e617. PubMed ID: 36169252
[TBL] [Abstract][Full Text] [Related]
10. A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells.
Beaudoin-Bussières G; Richard J; Prévost J; Goyette G; Finzi A
STAR Protoc; 2021 Dec; 2(4):100851. PubMed ID: 34541555
[TBL] [Abstract][Full Text] [Related]
11. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.
Tormo N; Giménez E; Martínez-Navarro M; Albert E; Navalpotro D; Torres I; Gimeno C; Navarro D
Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):657-662. PubMed ID: 35165804
[TBL] [Abstract][Full Text] [Related]
12. B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain.
Rouers A; Tay MZ; Ng LFP; Renia L
STAR Protoc; 2023 Mar; 4(1):102130. PubMed ID: 36853725
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of SARS-CoV-2 peptide stimulation and measurement of cytokine output by intracellular flow cytometry and bio-plex analysis.
Taylor JV; Callery EL; Rowbottom A
J Immunol Methods; 2023 Nov; 522():113556. PubMed ID: 37683822
[TBL] [Abstract][Full Text] [Related]
14. Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids.
Eriksen AZ; Møller R; Makovoz B; tenOever BR; Blenkinsop TA
STAR Protoc; 2022 Jun; 3(2):101383. PubMed ID: 35664254
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.
Li Y; Lai DY; Tao SC
STAR Protoc; 2021 Sep; 2(3):100707. PubMed ID: 34308376
[TBL] [Abstract][Full Text] [Related]
16. Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape.
Suryadevara N; Gilchuk P; Zost SJ; Mittal N; Zhao LL; Crowe JE; Carnahan RH
STAR Protoc; 2022 Jun; 3(2):101387. PubMed ID: 35578733
[TBL] [Abstract][Full Text] [Related]
17. Protocol to quantify and characterize contact between T cells and antigen-presenting cells in the antigen-draining lymph nodes of mice using flow cytometry.
Tatsumi N; Davila-Pagan A; Kumamoto Y
STAR Protoc; 2022 Dec; 3(4):101845. PubMed ID: 36595900
[TBL] [Abstract][Full Text] [Related]
18. Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S.
Zheng J; Channappanavar R; Perlman S
STAR Protoc; 2023 Feb; 4(2):102171. PubMed ID: 36920912
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Antigen-Specific T and B Cells for Monitoring Immune Protection Against SARS-CoV-2.
De Biasi S; Paolini A; Lo Tartaro D; Gibellini L; Cossarizza A
Curr Protoc; 2023 Jan; 3(1):e636. PubMed ID: 36598346
[TBL] [Abstract][Full Text] [Related]
20. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay.
Nasser H; Shimizu R; Ito J; ; Saito A; Sato K; Ikeda T
STAR Protoc; 2022 Dec; 3(4):101773. PubMed ID: 36313538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
